HomeClinical TrialsAvailable Clinical Trials

Available Advanced Solid Tumors Clinical Trials

To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724).

Email: askrpci@roswellpark.org

A Phase 1 Study to Evaluate the Safety and Pharmacokinetic Profile of CBLB502 in Patients with Advanced Cancers
(SWOG S0805) Phase II Study of Combination of Hyper-CVAD and Dasatinib With or Without Allogenetic Stem Cell Transplant in Patients with Philadelphia (Ph) Chromosome Positive and/or Bcr-Abl Positive Acute Lymphoblastic Leu...
An Open-Label, Dose Escalation study of Paricalcitol (Zemplar TM) {19-NOR-1 ALPHA, 25-(OH)2 D2] in Combination with Gemcitabine (Gemzar) [2',2' Diflurodeoxycytidine] in patients with advanced Malignancies
A Phase 1 Clinical Trial of mTOR Inhibition With Rapamycin for Enhancing Intranodal Dendritic Cell Vaccine Induced anti-Tumor Immunity In Patients with NY-ESO-1 Expressing Solid Tumors - Opening Soon
(CALGB 10701) A Phase II Study Of Dasatinib (Sprycel®) (IND #73969, NSC #732517) As Primary Therapy Followed by Transplantation For Adults >/= 50 Years With Newly Diagnosed PH+ Acute Lymphoblastic Leukemia by CALGB, ECOG,...
A Phase II Study of Induction (Daunorubicin/Cytarabine) and Consolidation (High-Dose Cytarabine) Chemotherapy Plus Dasatinib (NSC# 732517, IND#73969) and Continuation Therapy with Dasatinib Alone in Newly Diagnosed patient...
(COG ARST08P1) A Pilot Study to Evaluate Novel Agents (Temozolomide and Cixutumumab [IMC-A12, Anti-IGF-IR Monoclonal Antibody, IND #100947, NSC #742460]) in Combination with Intensive Multi-Agent Interval Compressed Therap...
Ofatumumab (O) in Combination With Chemotherapy: Hyper-Fractionated Cyclophosphamide, Doxorubicin, Vincristine and Dexamethasone (O-HyperCVAD) Alternating With Ofatumumab High-Dose Cytarabine and Methotrexate (O-MA) for...
(MM-121-06-01-06) A Phase I, Pharmacologic and Pharmacodynamic Study of MM-121 in Combination with Multiple Anticancer Therapies in Patients with Advanced Solid Tumors
A Phase 1 Study of Evaluate the Safety, Tolerability and Efficacy of SCH 900353 in Subjects with Advanced Solid Tumors (Protocol No. P06203)
Phase I, Open-Label, Multicenter, Dose-Escalation, Multidose Study of BMS-936559 (MDX-1105) Administered Every 14 Days in Subjects with Selected Advanced or Recurrent Solid Tumors (CA210001 (MDX1105-01))
A Phase I Study of Sorafenib in Combination with the Histone Deacetylase inhibitor, Entinostat in Patients with Advanced Cancers
(COG ACCL0934) A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)
A Phase I, Open-Label, Non-Randomized, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TL32711 in Adults with Refractory Solid Tumors or Lymphoma
(TL32711-POC-0078-PTL) A Phase 1B/2A, Open-Label, Non-Randomized, Multi-Arm Study of TL32711 in Combination with Chemotherapy in Subjects with Advanced or Metastatic Solid Tumors
Evaluation of Quality-of-Life (QOL) Assessment in Patients with Advanced Solid Malignancies as Screening Tool- Pilot Study on Implications on Eligibility and Adverse Events
(COG ADVL0921) A Phase II Study of MLN8237 (IND #102984), A Selective Aurora A Kinase Inhibitor in Children with Recurrent/Refractory Solid Tumors and Leukemias
A Phase I Study of Therapeutic Cancer Vaccine IMF-001 in Patients with Malignancies Expressing NY-ESO-1 (IMF001-PRT001)
A Phase I, Open-Label, Dose-Escalation Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of the P13K/MTOR Inhibitor PF-04691502 in Adult Patients with Advanced Malignant Solid Tumors
Survey Assessment of Advanced Minimally Invasive Surgery Training During Surgical Oncology Fellowship
(CLR 10-23) A Phase I Pharmacokinetic and Safety Study of Paclitaxel Injection Concentrate for Nano-Disersion (PICN) Alone and in Combination with Carboplatin in Subjects with Advanced Solid Malignancies
A Phase I Dose Escalation Study of ARQ197 Administered in Combination with Sorafenib in Adult Patients with Advanced Solid Tumors
ChemoFx® PRO, a post-market data collection study utilizing physician reported outcomes

Cancer Talk Blog
Good Day Sunshine? Vitamin D and Cancer

Can "the sunshine vitamin" play a role in preventing and treating cancer? Find out what Roswell Park Cancer Institute scientists and clinicians are learning about the inspiring potential of vitamin D for the future of cancer treatment. Featuring an interview with graduate student Sarah Mazzilli and Pamela Hershberger, PhD of Roswell Park's Department of Pharmacology and...

Read more

Latest Video

Ask A Question

Do you have a cancer question you’d like RPCI cancer experts to address? Submit a topic for consideration.

New to RSS? Learn More

close